A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Clinical trial NCT01808482 · TERMINATED
Trial details
- NCT number
- NCT01808482
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-13
- Primary completion
- 2013-08-06
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.